Methandrostenolone

Methandrostenolone

SCHEMBL4435272

CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@H]3CC[C@@]21C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AR

The experimentally established mechanism targets of Methandrostenolone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
MAPT P10636 2/20 1.00
CYP19A1 P11511 9/20 0.65
CYP3A4 P08684 1/20 0.65
GUSB P08236 1/20 0.65
SHBG P04278 2/20 0.63
ALDH1A1 P00352 2/20 0.60
NR3C1 P04150 2/20 0.60
PGR P06401 2/20 0.60
ADRA1A P35348 1/20 0.60
HTR2B P41595 1/20 0.60
HSD17B10 Q99714 3/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
HIF1A Q16665 1/20 0.53
SLC29A1 Q99808 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methandrostenolone SCHEMBL140928 1.00 LMNA (1.00) LMNAMAPTCYP19A1CYP3A4GUSB
Methandrostenolone SCHEMBL28423591 1.00 LMNA (1.00) LMNAMAPTCYP19A1CYP3A4GUSB
Methandrostenolone SCHEMBL8408550 1.00 LMNA (1.00) LMNAMAPTCYP19A1CYP3A4GUSB
Methandrostenolone SCHEMBL21177905 1.00 LMNA (1.00) LMNAMAPTCYP19A1CYP3A4GUSB
Methandrostenolone SCHEMBL16755284 1.00 LMNA (1.00) LMNAMAPTCYP19A1CYP3A4GUSB
Methandrostenolone SCHEMBL6395376 0.90 LMNA (0.81) LMNAMAPTCYP19A1CYP3A4GUSB
SCHEMBL5270893 0.90 LMNA (0.81) LMNAMAPTCYP19A1CYP3A4ALDH1A1
SCHEMBL10861103 0.90 LMNA (0.81) LMNAMAPTCYP19A1CYP3A4ALDH1A1
SCHEMBL17775770 0.87 LMNA (0.77) LMNAMAPTCYP19A1CYP3A4
SCHEMBL27046922 0.86 LMNA (0.75) LMNAMAPTCYP19A1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210199646-A1 SAMPLE DEPLETION AND ENRICHMENT TO IMPROVE THE QUALITY OF DIAGNOSTIC TEST RESULTS VERAVAS, INC. 2021-07-01 US disclosed
US-10948484-B2 Sample depletion and enrichment to improve the quality of diagnostic test results VERAVAS, INC. (US) 2021-03-16 US disclosed
US-20190137484-A9 Sample depletion and enrichment to improve the quality of diagnostic test results VERAVAS, INC. (US) 2019-05-09 US disclosed
US-20180292394-A1 Sample depletion and enrichment to improve the quality of diagnostic test results SOLDO JOSHUA CAINE (US) 2018-10-11 US disclosed
US-20150152348-A1 SYSTEMS AND METHODS FOR COLLECTING, TRANSPORTING AND REPURPOSING OR DESTROYING UNUSED PHARMACEUTICALS SHARPS COMPLIANCE, INC. OF TEXAS 2015-06-04 US disclosed
EP-2069790-B1 BINDING SURFACES FOR AFFINITY ASSAYS BECKMAN COULTER INC (US) 2015-04-29 EP disclosed
US-8518714-B2 Binding surfaces for affinity assays BECKMAN COULTER, INC. (US) 2013-08-27 US disclosed
EP-2069790-A2 BINDING SURFACES FOR AFFINITY ASSAYS Beckman Coulter, Inc. (US) 2009-06-17 EP disclosed
US-20080207601-A1 Methods of and Compositions For the Prevention of Anxiety, Substance Abuse, and Dependence HYTHIAM , INC. (US) 2008-08-28 US disclosed
US-20080176340-A1 Binding surfaces for affinity assays BECKMAN COULTER, INC. (US) 2008-07-24 US disclosed
WO-2008057366-A2 BINDING SURFACES FOR AFFINITY ASSAYS BECKMAN COULTER, INC. (US) 2008-05-15 WO disclosed
US-20080075772-A1 PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS ACCU-BREAK TECHNOLOGIES, INC. 2008-03-27 US disclosed
EP-1868593-A2 IMPROVED METHODS OF AND COMPOSITIONS FOR THE PREVENTION OF ANXIETY, SUBSTANCE ABUSE, AND DEPENDENCE Hythiam, Inc. (US) 2007-12-26 EP disclosed
US-20070141710-A1 Stable calibrators for immunoassays BECKMAN COULTER, INC. (US) 2007-06-21 US disclosed
WO-2006110642-A2 IMPROVED METHODS OF AND COMPOSITIONS FOR THE PREVENTION OF ANXIETY, SUBSTANCE ABUSE, AND DEPENDENCE HYTHIAM, INC. (US) 2006-10-19 WO disclosed